Hongkong XinRunde Chemical Co., Ltd

 

Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsPharmaceutical Intermediate

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder
Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder

Large Image :  Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder Get Best Price

Product Details:

Place of Origin: China
Brand Name: XRD
Certification: GMP
Model Number: 872365-14-5

Payment & Shipping Terms:

Minimum Order Quantity: negotiable
Price: Inquiry for Negotiable
Packaging Details: 1-2 kg / aluminum foil bag, 25kg/ drum, as required
Delivery Time: 5-7 days after received your payments
Payment Terms: T/T bank, Western Union, Bitcoin, Etc
Supply Ability: 100KG/ Month
Detailed Product Description
CAS: 872365-14-5 Product Name: Fevipiprant
Type: Pharmaceutical Intermediate Appearance: White Powder
Usage: Muscle Growth Alias: Fevipiprant
Assay: 99% Key Words: Fevipiprant
High Light:

raw materials for pharma industry

,

pharmaceutical grade raw materials

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder
 
Product Describtion
 

Fevipiprant Basic information

Product Name:

Fevipiprant

Synonyms:

Fevipiprant;Fevipipran;NVP-QAW039;Fevipiprant(NVP-QAW039);QAW039

CAS:

872365-14-5

Appearance

white fine powder

Key words:

Fevipiprant,NVP-QAW039,QAW039

 
 
 
What's the Anti hair loss treatment drug CAS 872365-14-5 fevipiprant bulk NVP-QAW039 powder

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]
Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

 

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder 0

Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder 1

Releated Products for hair loss treatment

 

 

RU58841

CAS 154992-24-2

Dutasteride

CAS 164656-23-9

Setipiprant

CAS 866460-33-5

S-equol

CAS 531-95-3

OC000459

CAS 851723-84-7

Minoxidil

CAS 38304-91-5

CB-03-01

CAS 19608-29-8

Bimatoprost

CAS 155206-00-1

Finasteride

CAS 98319-26-7

Fevipiprant

CAS 872365-14-5

 
 
Function & Application
 

Anti hair loss treatment drug CAS 872365-14-5 fevipiprant bulk NVP-QAW039 powder Function

Fevipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.

 

 

 
Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder 2
 
 
 
 
Anti Hair Loss Treatment Drug CAS 872365-14-5 Fevipiprant Bulk NVP-QAW039 Powder

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: Cherry feng

Tel: +8615102730682

Send your inquiry directly to us